ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Insulin Drug Delivery Devices Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-37X10341
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global and United States Insulin Drug Delivery Devices Market Report Forecast 2022 2028
BUY CHAPTERS

Global Insulin Drug Delivery Devices Market Research Report 2025

Code: QYRE-Auto-37X10341
Report
August 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic Inc
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas

Insulin Drug Delivery Devices Market Size

The global market for Insulin Drug Delivery Devices was valued at US$ 15320 million in the year 2024 and is projected to reach a revised size of US$ 20960 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Insulin Drug Delivery Devices Market

Insulin Drug Delivery Devices Market

Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Insulin Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Drug Delivery Devices.
The Insulin Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Insulin Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Insulin Drug Delivery Devices Market Report

Report Metric Details
Report Name Insulin Drug Delivery Devices Market
Accounted market size in year US$ 15320 million
Forecasted market size in 2031 US$ 20960 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Homecare
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Dance Biopharm, Roche, Tandem Diabetes Care, Animas
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Insulin Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Insulin Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Insulin Drug Delivery Devices Market growing?

Ans: The Insulin Drug Delivery Devices Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Insulin Drug Delivery Devices Market size in 2031?

Ans: The Insulin Drug Delivery Devices Market size in 2031 will be US$ 20960 million.

Who are the main players in the Insulin Drug Delivery Devices Market report?

Ans: The main players in the Insulin Drug Delivery Devices Market are Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Beta Bionics, Dance Biopharm, Roche, Tandem Diabetes Care, Animas

What are the Application segmentation covered in the Insulin Drug Delivery Devices Market report?

Ans: The Applications covered in the Insulin Drug Delivery Devices Market report are Hospitals, Clinics, Homecare, Others

What are the Type segmentation covered in the Insulin Drug Delivery Devices Market report?

Ans: The Types covered in the Insulin Drug Delivery Devices Market report are Syringes, Insulin Pens, Jet Injectors, Insulin Pumps

Recommended Reports

Insulin Delivery Devices

Diabetes & Insulin

Drug Delivery Devices

1 Insulin Drug Delivery Devices Market Overview
1.1 Product Definition
1.2 Insulin Drug Delivery Devices by Type
1.2.1 Global Insulin Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Syringes
1.2.3 Insulin Pens
1.2.4 Jet Injectors
1.2.5 Insulin Pumps
1.3 Insulin Drug Delivery Devices by Application
1.3.1 Global Insulin Drug Delivery Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare
1.3.5 Others
1.4 Global Insulin Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Insulin Drug Delivery Devices Revenue 2020-2031
1.4.2 Global Insulin Drug Delivery Devices Sales 2020-2031
1.4.3 Global Insulin Drug Delivery Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Insulin Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Insulin Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Insulin Drug Delivery Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Insulin Drug Delivery Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Insulin Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Drug Delivery Devices, Product Type & Application
2.7 Global Key Manufacturers of Insulin Drug Delivery Devices, Date of Enter into This Industry
2.8 Global Insulin Drug Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Insulin Drug Delivery Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Drug Delivery Devices Players Market Share by Revenue
2.8.3 Global Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Drug Delivery Devices Market Scenario by Region
3.1 Global Insulin Drug Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Insulin Drug Delivery Devices Sales by Region: 2020-2031
3.2.1 Global Insulin Drug Delivery Devices Sales by Region: 2020-2025
3.2.2 Global Insulin Drug Delivery Devices Sales by Region: 2026-2031
3.3 Global Insulin Drug Delivery Devices Revenue by Region: 2020-2031
3.3.1 Global Insulin Drug Delivery Devices Revenue by Region: 2020-2025
3.3.2 Global Insulin Drug Delivery Devices Revenue by Region: 2026-2031
3.4 North America Insulin Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Insulin Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Insulin Drug Delivery Devices Sales by Country (2020-2031)
3.4.3 North America Insulin Drug Delivery Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insulin Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Insulin Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Insulin Drug Delivery Devices Sales by Country (2020-2031)
3.5.3 Europe Insulin Drug Delivery Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Drug Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Drug Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Insulin Drug Delivery Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Insulin Drug Delivery Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Insulin Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Insulin Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Insulin Drug Delivery Devices Sales by Country (2020-2031)
3.7.3 Latin America Insulin Drug Delivery Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insulin Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Drug Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Insulin Drug Delivery Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Insulin Drug Delivery Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Insulin Drug Delivery Devices Sales by Type (2020-2031)
4.1.1 Global Insulin Drug Delivery Devices Sales by Type (2020-2025)
4.1.2 Global Insulin Drug Delivery Devices Sales by Type (2026-2031)
4.1.3 Global Insulin Drug Delivery Devices Sales Market Share by Type (2020-2031)
4.2 Global Insulin Drug Delivery Devices Revenue by Type (2020-2031)
4.2.1 Global Insulin Drug Delivery Devices Revenue by Type (2020-2025)
4.2.2 Global Insulin Drug Delivery Devices Revenue by Type (2026-2031)
4.2.3 Global Insulin Drug Delivery Devices Revenue Market Share by Type (2020-2031)
4.3 Global Insulin Drug Delivery Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Insulin Drug Delivery Devices Sales by Application (2020-2031)
5.1.1 Global Insulin Drug Delivery Devices Sales by Application (2020-2025)
5.1.2 Global Insulin Drug Delivery Devices Sales by Application (2026-2031)
5.1.3 Global Insulin Drug Delivery Devices Sales Market Share by Application (2020-2031)
5.2 Global Insulin Drug Delivery Devices Revenue by Application (2020-2031)
5.2.1 Global Insulin Drug Delivery Devices Revenue by Application (2020-2025)
5.2.2 Global Insulin Drug Delivery Devices Revenue by Application (2026-2031)
5.2.3 Global Insulin Drug Delivery Devices Revenue Market Share by Application (2020-2031)
5.3 Global Insulin Drug Delivery Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk Insulin Drug Delivery Devices Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Insulin Drug Delivery Devices Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Insulin Drug Delivery Devices Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Eli Lilly
6.4.1 Eli Lilly Company Information
6.4.2 Eli Lilly Description and Business Overview
6.4.3 Eli Lilly Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Lilly Insulin Drug Delivery Devices Product Portfolio
6.4.5 Eli Lilly Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Company Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medtronic Insulin Drug Delivery Devices Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Beta Bionics
6.6.1 Beta Bionics Company Information
6.6.2 Beta Bionics Description and Business Overview
6.6.3 Beta Bionics Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Beta Bionics Insulin Drug Delivery Devices Product Portfolio
6.6.5 Beta Bionics Recent Developments/Updates
6.7 Dance Biopharm
6.7.1 Dance Biopharm Company Information
6.7.2 Dance Biopharm Description and Business Overview
6.7.3 Dance Biopharm Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dance Biopharm Insulin Drug Delivery Devices Product Portfolio
6.7.5 Dance Biopharm Recent Developments/Updates
6.8 Roche
6.8.1 Roche Company Information
6.8.2 Roche Description and Business Overview
6.8.3 Roche Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Roche Insulin Drug Delivery Devices Product Portfolio
6.8.5 Roche Recent Developments/Updates
6.9 Tandem Diabetes Care
6.9.1 Tandem Diabetes Care Company Information
6.9.2 Tandem Diabetes Care Description and Business Overview
6.9.3 Tandem Diabetes Care Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Tandem Diabetes Care Insulin Drug Delivery Devices Product Portfolio
6.9.5 Tandem Diabetes Care Recent Developments/Updates
6.10 Animas
6.10.1 Animas Company Information
6.10.2 Animas Description and Business Overview
6.10.3 Animas Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Animas Insulin Drug Delivery Devices Product Portfolio
6.10.5 Animas Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Drug Delivery Devices Industry Chain Analysis
7.2 Insulin Drug Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Drug Delivery Devices Production Mode & Process Analysis
7.4 Insulin Drug Delivery Devices Sales and Marketing
7.4.1 Insulin Drug Delivery Devices Sales Channels
7.4.2 Insulin Drug Delivery Devices Distributors
7.5 Insulin Drug Delivery Devices Customer Analysis
8 Insulin Drug Delivery Devices Market Dynamics
8.1 Insulin Drug Delivery Devices Industry Trends
8.2 Insulin Drug Delivery Devices Market Drivers
8.3 Insulin Drug Delivery Devices Market Challenges
8.4 Insulin Drug Delivery Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic Inc
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas
List of Tables
 Table 1. Global Insulin Drug Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Insulin Drug Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Insulin Drug Delivery Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Insulin Drug Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Insulin Drug Delivery Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Insulin Drug Delivery Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Insulin Drug Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Insulin Drug Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Insulin Drug Delivery Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Insulin Drug Delivery Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Insulin Drug Delivery Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Insulin Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Drug Delivery Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Insulin Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Insulin Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Insulin Drug Delivery Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Insulin Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Insulin Drug Delivery Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Insulin Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Insulin Drug Delivery Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Insulin Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Insulin Drug Delivery Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Insulin Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Insulin Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Insulin Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Insulin Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Insulin Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Insulin Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Insulin Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Insulin Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Insulin Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Insulin Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Insulin Drug Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Insulin Drug Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Insulin Drug Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Insulin Drug Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Insulin Drug Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Insulin Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Insulin Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Insulin Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Insulin Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Insulin Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Insulin Drug Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Insulin Drug Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Insulin Drug Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Insulin Drug Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Insulin Drug Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Insulin Drug Delivery Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Insulin Drug Delivery Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Insulin Drug Delivery Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Insulin Drug Delivery Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Insulin Drug Delivery Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Insulin Drug Delivery Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Insulin Drug Delivery Devices Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Insulin Drug Delivery Devices Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Insulin Drug Delivery Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Insulin Drug Delivery Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Insulin Drug Delivery Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Insulin Drug Delivery Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Insulin Drug Delivery Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Insulin Drug Delivery Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Insulin Drug Delivery Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Insulin Drug Delivery Devices Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Insulin Drug Delivery Devices Price (USD/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk Insulin Drug Delivery Devices Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Insulin Drug Delivery Devices Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. BD Insulin Drug Delivery Devices Product
 Table 84. BD Recent Developments/Updates
 Table 85. Eli Lilly Company Information
 Table 86. Eli Lilly Description and Business Overview
 Table 87. Eli Lilly Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Eli Lilly Insulin Drug Delivery Devices Product
 Table 89. Eli Lilly Recent Developments/Updates
 Table 90. Medtronic Company Information
 Table 91. Medtronic Description and Business Overview
 Table 92. Medtronic Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Medtronic Insulin Drug Delivery Devices Product
 Table 94. Medtronic Recent Developments/Updates
 Table 95. Beta Bionics Company Information
 Table 96. Beta Bionics Description and Business Overview
 Table 97. Beta Bionics Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Beta Bionics Insulin Drug Delivery Devices Product
 Table 99. Beta Bionics Recent Developments/Updates
 Table 100. Dance Biopharm Company Information
 Table 101. Dance Biopharm Description and Business Overview
 Table 102. Dance Biopharm Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Dance Biopharm Insulin Drug Delivery Devices Product
 Table 104. Dance Biopharm Recent Developments/Updates
 Table 105. Roche Company Information
 Table 106. Roche Description and Business Overview
 Table 107. Roche Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Roche Insulin Drug Delivery Devices Product
 Table 109. Roche Recent Developments/Updates
 Table 110. Tandem Diabetes Care Company Information
 Table 111. Tandem Diabetes Care Description and Business Overview
 Table 112. Tandem Diabetes Care Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Tandem Diabetes Care Insulin Drug Delivery Devices Product
 Table 114. Tandem Diabetes Care Recent Developments/Updates
 Table 115. Animas Company Information
 Table 116. Animas Description and Business Overview
 Table 117. Animas Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Animas Insulin Drug Delivery Devices Product
 Table 119. Animas Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Insulin Drug Delivery Devices Distributors List
 Table 123. Insulin Drug Delivery Devices Customers List
 Table 124. Insulin Drug Delivery Devices Market Trends
 Table 125. Insulin Drug Delivery Devices Market Drivers
 Table 126. Insulin Drug Delivery Devices Market Challenges
 Table 127. Insulin Drug Delivery Devices Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Insulin Drug Delivery Devices
 Figure 2. Global Insulin Drug Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Insulin Drug Delivery Devices Market Share by Type: 2024 & 2031
 Figure 4. Syringes Product Picture
 Figure 5. Insulin Pens Product Picture
 Figure 6. Jet Injectors Product Picture
 Figure 7. Insulin Pumps Product Picture
 Figure 8. Global Insulin Drug Delivery Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Insulin Drug Delivery Devices Market Share by Application: 2024 & 2031
 Figure 10. Hospitals
 Figure 11. Clinics
 Figure 12. Homecare
 Figure 13. Others
 Figure 14. Global Insulin Drug Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Insulin Drug Delivery Devices Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Insulin Drug Delivery Devices Sales (2020-2031) & (K Units)
 Figure 17. Global Insulin Drug Delivery Devices Average Price (USD/Unit) & (2020-2031)
 Figure 18. Insulin Drug Delivery Devices Report Years Considered
 Figure 19. Insulin Drug Delivery Devices Sales Share by Manufacturers in 2024
 Figure 20. Global Insulin Drug Delivery Devices Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Insulin Drug Delivery Devices Players: Market Share by Revenue in Insulin Drug Delivery Devices in 2024
 Figure 22. Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Insulin Drug Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Insulin Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 25. North America Insulin Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Insulin Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 29. Europe Insulin Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Insulin Drug Delivery Devices Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Insulin Drug Delivery Devices Revenue Market Share by Region (2020-2031)
 Figure 37. China Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Insulin Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Insulin Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Insulin Drug Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Insulin Drug Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Insulin Drug Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Insulin Drug Delivery Devices by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Insulin Drug Delivery Devices by Type (2020-2031)
 Figure 59. Global Insulin Drug Delivery Devices Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Insulin Drug Delivery Devices by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Insulin Drug Delivery Devices by Application (2020-2031)
 Figure 62. Global Insulin Drug Delivery Devices Price (USD/Unit) by Application (2020-2031)
 Figure 63. Insulin Drug Delivery Devices Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Insulin Delivery Devices Market Research Report 2024
Global Diabetes Insulin Delivery Pens Market Insights Forecast to 2030
Insulin Pen and Pump Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diabetes Treatment Medical Devices Market Research Report 2024
Global Insulin Injection Devices Market Research Report 2024
Global Insulin Pen Injectors Market Insights Forecast to 2030
Global Portable Diabetes Insulin Delivery Pen Market Research Report 2024
Insulin Injection Pen Market
Global Human Insulin Drugs And Delivery Devices Market Insights Forecast to 2030
Safety Insulin Pen Needles Market
Global Standard Insulin Pen Needles Market Insights Forecast to 2030
Global Human Insulin Delivery System Market Insights Forecast to 2030
Global Insulin Injection Equipment Market Research Report 2025
Insulin Syringes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Injection Consumables Market Research Report 2025
Global Insulin Pump Market Research Report 2025
Global Automated Insulin Delivery Device Market Research Report 2024
Global Insulin Infusion Pumps Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Insulin Pen and Pen Needle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Insulin Pen Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions